Rosenbaum R L, Barzel U S
J Am Geriatr Soc. 1981 May;29(5):221-3. doi: 10.1111/j.1532-5415.1981.tb01770.x.
Among 27 ambulatory aged patients receiving thyroxine therapy for hypothyroidism, 4 had the "failing thyroid syndrome" (FTS) and 23 had frank clinical hypothyroidism. Patients with FTS are asymptomatic and the subnormal thyroid function is recognized only by a high level of serum thyrotropin (TSH) with a normal level of thyroid hormone (thyroxine or triiodothyronine). They require a smaller dosage of thyroid hormone for replacement initially. Identification of these cases through routine blood analyses for TSH in patients at risk (those with a history of Graves' disease or Hashimoto's thyroiditis) may permit early treatment of incipient hypothyroidism and the prevention of clinical hypothyroidism. Since there is a reduction in the thyroxine dosage required for complete replacement with age, the expected final replacement dosage when the thyroid fails completely is less than that reported for younger adults. This is true for patients with FTS, for patients with newly diagnosed clinical hypothyroidism, and for patients with long-established hypothyroidism receiving replacement therapy. The thyroid replacement dosage should be adjusted both for age and for body weight to avoid overdosage and thyroid toxicity, to which the elderly are particularly sensitive.
在27名接受甲状腺素治疗甲状腺功能减退症的非卧床老年患者中,4例患有“甲状腺功能减退综合征”(FTS),23例患有明显的临床甲状腺功能减退症。FTS患者无症状,甲状腺功能异常仅通过高水平的血清促甲状腺激素(TSH)和正常水平的甲状腺激素(甲状腺素或三碘甲状腺原氨酸)来识别。他们最初需要较小剂量的甲状腺激素进行替代治疗。通过对有风险的患者(有格雷夫斯病或桥本甲状腺炎病史者)进行常规血液促甲状腺激素分析来识别这些病例,可能有助于早期治疗初期甲状腺功能减退症并预防临床甲状腺功能减退症。由于随着年龄增长,完全替代所需的甲状腺素剂量会减少,因此甲状腺完全功能减退时预期的最终替代剂量低于年轻成年人的报告剂量。这对于FTS患者、新诊断的临床甲状腺功能减退症患者以及接受替代治疗的长期甲状腺功能减退症患者都是如此。应根据年龄和体重调整甲状腺替代剂量,以避免过量用药和甲状腺毒性,老年人对此尤为敏感。